A randomized placebo controlled trial testing the effect of Zoledronic Acid on Hip osteoarthritis
This research trial is investigating the effects of a medicine called Zoledronic Acid on hip osteoarthritis. Osteoarthritis is a common condition that causes pain and stiffness in joints. The study aims to find out if this medication can help reduce symptoms or slow down the condition. Participants will be given either Zoledronic Acid or a placebo (a dummy treatment, like a sugar pill) to see which one has an effect. This is a "Phase IV" study, which means it's looking further into a treatment that is already approved for other uses. If you have hip osteoarthritis and are aged 18 or over, you might be able to take part, regardless of your gender. Participation helps medical science understand treatments better.
At a glance
What is this study about?
This research study is focused on a condition called hip osteoarthritis. Osteoarthritis is a very common type of arthritis where the smooth, slippery surface inside your joints, called cartilage, wears away over time. This can cause pain, stiffness, and difficulty moving your hip. Scientists are constantly looking for ways to better manage this condition and improve people's quality of life.
The main goal of this particular study is to see if a medicine called Zoledronic Acid can help people with hip osteoarthritis. This medicine is already approved and used for other health problems, but researchers want to understand if it could also be beneficial for hip osteoarthritis. By carefully studying its effects, they hope to learn if it can reduce symptoms or prevent the condition from getting worse.
This is a "Phase IV" trial, which means it's a further step in understanding a treatment already in use. These types of studies are important because they help doctors learn more about how medicines work in real-world situations, including any long-term effects or benefits. They are crucial for improving how we treat common conditions like hip osteoarthritis.
Key takeaways
- This study investigates Zoledronic Acid for hip osteoarthritis.
- It's a 'Phase IV' trial, looking at an existing medicine for a new use.
- Participants will receive either Zoledronic Acid or a placebo.
- Anyone 18+ with hip osteoarthritis can be eligible.
- Participation helps advance understanding of treatments.
- You can withdraw from the study at any time.
Who may be eligible?
To join this study, you need to have been diagnosed with osteoarthritis in your hip. This is very important, as the study is specifically looking at how the medicine affects this particular condition.
Only adults aged 18 years and older can take part. There is no upper age limit, so people of all adult ages are welcome to consider joining. The study is open to everyone, regardless of whether you are male or female.
There will be other, more detailed requirements that the study team will discuss with you. These usually involve checking your general health, current medications, and other medical conditions to make sure the study is safe and suitable for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have a diagnosis of hip osteoarthritis?
- Am I 18 years old or older?
- Am I comfortable attending regular appointments at a clinic?
- Am I willing to take study medication as directed?
- Am I open to the possibility of receiving a placebo?
- Do I have any other significant health conditions that might prevent me from joining?
What does participation involve?
If you decide to take part, you'll be assigned by chance to receive either the study medicine, Zoledronic Acid, or a placebo (a treatment that looks like the active medicine but contains no active drug). You won't know which one you're receiving, and neither will your study doctor, to ensure the results are fair.
You will have several appointments at the study clinic throughout the trial. These visits will involve various health checks, including physical examinations, blood tests, and possibly scans of your hip to monitor how your condition is progressing. You'll also be asked about your pain levels and how you're feeling overall. The study team will guide you on how and when to take the medication.
The total duration of the study will be explained in detail by the research team. During this time, it's important to attend all scheduled appointments and report any changes in your health or any side effects you experience. Regular follow-up appointments will continue even after you finish taking the study medication to ensure your safety and gather all necessary information.
Potential risks and benefits
Locations (1)
- —UnverifiedNorway
Common questions
What is Zoledronic Acid?
Zoledronic Acid is a medicine that is currently used for other health conditions. This study is testing if it can also help people with hip osteoarthritis.
What is a placebo?
A placebo is a 'dummy' treatment that looks just like the real medicine but contains no active drug. It helps researchers fairly compare how well the actual medicine works.
Who can join this study?
Adults aged 18 and over, of any gender, who have hip osteoarthritis can be considered for this study.
Do I have to pay to join the study?
No, participating in a clinical trial typically does not cost you any money. All study-related treatments and tests are usually covered by the research sponsor.
Can I leave the study at any time?
Yes, you are free to leave the study at any point without it affecting your current or future medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.